PMC:7344504 / 4233-4730
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T10 | 252-256 | Body_part | denotes | gene | http://purl.org/sig/ont/fma/fma74402 |
| T11 | 264-269 | Body_part | denotes | Blood | http://purl.org/sig/ont/fma/fma9670 |
| T12 | 306-317 | Body_part | denotes | nasopharynx | http://purl.org/sig/ont/fma/fma54878 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T7 | 264-269 | Body_part | denotes | Blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
| T8 | 306-317 | Body_part | denotes | nasopharynx | http://purl.obolibrary.org/obo/UBERON_0001728 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 122 | 186-196 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 123 | 361-368 | Species | denotes | patient | Tax:9606 |
| 124 | 57-68 | Chemical | denotes | chloroquine | MESH:D002738 |
| 125 | 35-55 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T29 | 35-43 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T30 | 46-55 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T31 | 186-194 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T28 | 204-205 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T29 | 252-256 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | gene |
| T30 | 264-269 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | Blood |
| T31 | 264-269 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | Blood |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T30 | 57-68 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T37 | 0-181 | Sentence | denotes | Because of the high probability of SARS-CoV-2 infection, chloroquine treatment was started (600 mg and 300 mg on day 1, 300 mg q12h days 2–5), which was national policy at the time. |
| T38 | 182-263 | Sentence | denotes | The SARS-CoV-2 PCR of a nasopharyngeal swab was positive (Ct 30.59; E gene [12]). |
| T39 | 264-356 | Sentence | denotes | Blood cultures remained negative, as were nasopharynx bacterial cultures taken at admission. |
| T40 | 357-437 | Sentence | denotes | The patient was subsequently admitted to our general inpatient respiratory ward. |
| T41 | 438-497 | Sentence | denotes | An overview of her hospital course is depicted in Figure 2. |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32517166-31992387-60114384 | 258-260 | 31992387 | denotes | 12 |